
“The quality and coverage of B2B contact database are very impressive...”
Mark J.
`
+4
Nuvaira, Inc. develops innovative and groundbreaking therapies that aim to improve the lives of the more than 65 million people around the world with obstructive lung disease. Founded in 2008, Nuvaira was established to address clinical needs in the treatment of overactive airway nerves, a common disease feature of both COPD and asthma. Nuvaira is a privately held medical device company, headquartered in Minneapolis, Minnesota USA and has more than 75 patents issued and pending worldwide. The dNerva Lung Denervation System is CE Mark approved. The dNerva lung denervation system is under clinical investigation and is not commercially available in...
Copd,pulmonology,lung denervation,obstructive lung disease,interventional pulmonology,chronic obstructive lung disease,bronchoscopy,bronchology,and medical devices
Nuvaira, inc operates in the Medical device industry.
Nuvaira, inc's revenue is 11m - 100m
Nuvaira, inc has 11 - 50 employees.
Get Started with the Free Forever plan! No credit card needed. Enjoy up to 10,000 free email credits per month at no cost.
Start Prospecting from Clodura.AI's database of 600M+ verified B2B contacts and 120M+ direct dials along with 18M+ companies' org charts.
Unlock the prospect's contact details, including verified email, direct dials, add them to cadence, and close more deals.